Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Hellmann

Showing results (11-20 of 172) with videos related to

Pageof 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 10, 2019
Use of Circulating Tumor DNA for Cancer ImmunotherapyAlexandra Snyder, Michael P Morrissey, Matthew D Hellmann
JAMA Oncology|November 20, 2015
Medians and Milestones in Describing the Path to Cancer Cures: Telling "Tails"Matthew D Hellmann, Mark G Kris, Charles M Rudin
Advances in Immunology|March 1, 2016
Combinatorial Cancer ImmunotherapiesMatthew D Hellmann, Claire F Friedman, Jedd D Wolchok
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Chemotherapy for lung cancers: here to stayMark G Kris, Matthew D Hellmann, Jamie E Chaft
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2017
Reply to M. Nishino et alJarushka Naidoo, Tunc Iyriboz, Jane Cunningham, et al.
Cancer Cell|May 18, 2021
Translating inspiration from COVID-19 vaccine trials to innovations in clinical cancer researchNoura J Choudhury, Gregory J Riely, Paul J Sabbatini, et al.
Journal for Immunotherapy of Cancer|July 4, 2014
Opportunistic infections in patients treated with immunotherapy for cancerChrisann Kyi, Matthew D Hellmann, Jedd D Wolchok, et al.
The Annals of Thoracic Surgery|August 26, 2017
Initial Experience With Lung Cancer Resection After Treatment With T-Cell Checkpoint InhibitorsJamie E Chaft, Matthew D Hellmann, Moises J Velez, et al.
Cancer Discovery|May 14, 2020
Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung CancersJia Luo, Hira Rizvi, Jacklynn V Egger, et al.
JTO Clinical and Research Reports|September 30, 2021
Association Between the Early Discontinuation of Durvalumab and Poor Survival in Patients With Stage III NSCLCNarek Shaverdian, Michael Offin, Annemarie F Shepherd, et al.
Pageof 18

Showing results (11-20 of 172) with videos related to

Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 10, 2019
Use of Circulating Tumor DNA for Cancer ImmunotherapyAlexandra Snyder, Michael P Morrissey, Matthew D Hellmann
JAMA Oncology|November 20, 2015
Medians and Milestones in Describing the Path to Cancer Cures: Telling "Tails"Matthew D Hellmann, Mark G Kris, Charles M Rudin
Advances in Immunology|March 1, 2016
Combinatorial Cancer ImmunotherapiesMatthew D Hellmann, Claire F Friedman, Jedd D Wolchok
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Chemotherapy for lung cancers: here to stayMark G Kris, Matthew D Hellmann, Jamie E Chaft
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2017
Reply to M. Nishino et alJarushka Naidoo, Tunc Iyriboz, Jane Cunningham, et al.
Cancer Cell|May 18, 2021
Translating inspiration from COVID-19 vaccine trials to innovations in clinical cancer researchNoura J Choudhury, Gregory J Riely, Paul J Sabbatini, et al.
Journal for Immunotherapy of Cancer|July 4, 2014
Opportunistic infections in patients treated with immunotherapy for cancerChrisann Kyi, Matthew D Hellmann, Jedd D Wolchok, et al.
The Annals of Thoracic Surgery|August 26, 2017
Initial Experience With Lung Cancer Resection After Treatment With T-Cell Checkpoint InhibitorsJamie E Chaft, Matthew D Hellmann, Moises J Velez, et al.
Cancer Discovery|May 14, 2020
Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung CancersJia Luo, Hira Rizvi, Jacklynn V Egger, et al.
JTO Clinical and Research Reports|September 30, 2021
Association Between the Early Discontinuation of Durvalumab and Poor Survival in Patients With Stage III NSCLCNarek Shaverdian, Michael Offin, Annemarie F Shepherd, et al.
Pageof 18